中光學(002189.SZ):直接出口美國商品金額佔公司收入比重很少
格隆匯5月6日丨中光學(002189.SZ)在投資者互動平台表示,根據2024年公司出口數據顯示,直接出口美國商品金額佔公司收入比重很少,影響有限。為應對本次關税調整,公司主要採取的措施:一是加大市場多元化拓展。深化與現有海外客户的合作,鞏固市場份額。同時,持續擴大海外市場開拓力度,降低對單一海外市場的依賴。二是優化供應鏈管理。加強與供應商的交流,共同探討應對關税調整的策略,降低原材料的採購成本。三是提高產品創新和技術升級。通過創新提高產品性能和質量,打造差異化競爭優勢,滿足不同市場對高端光電產品的需求,提高國際市場形象和影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.